Busca avançada
Ano de início
Entree


Oxime-derived palladacycles bearing 2,6-lutidine: Synthesis, cytotoxicity evaluation and interactions with biomolecules

Texto completo
Autor(es):
Mostrar menos -
Polez, Ana M. R. ; Farias, Renan L. ; de Lima, Andresa A. ; Lazzarini, Ana Beatriz ; de Moura, Thales R. ; Velasques, Jecika M. ; Souza, Jessica Carolina ; Rocha, Fillipe V. ; Lima, Mauro Almeida ; Ellena, Javier ; Miranda, Victor Maia ; Deflon, Victor M. ; Moreira, Mariete B. ; Netto, Adelino V. G.
Número total de Autores: 14
Tipo de documento: Artigo Científico
Fonte: Journal of Molecular Structure; v. 1321, p. 11-pg., 2024-10-05.
Resumo

In this study, we report the synthesis, characterization and biological studies on new organometallic compounds bearing orthopalladated oximes and 2,6-lutidine. Cyclopalladated compounds of the type [PdCl(C2,N-ox)(lut)] {ox: bzox = benzaldehydeoxime (1), aphox = acetophenoneoxime (2), tetrox = E-alpha-tetralone oxime (3); lut = 2,6-lutidine} have been obtained from the reaction between the suitable [Pd(C2,N-ox)(mu -Cl)]2 precursor with 2,6lutidine. The compounds have been characterized by elemental analyses, infrared (IR) and NMR spectroscopies. The molecular and crystal structures of 1 - 3 have been determined by single-crystal X-ray crystallography. The cytotoxic activity of compounds 1-3 has been evaluated towards breast (MCF-7 and MD-MBA-231) and lung (A549) human cancer cells along with human lung fibroblast (MRC-5). The level of cytotoxicity is dependent on the tested tumour cell line and the type of orthometallated oxime. The binding properties of the model compound 3 on ct-DNA have been studied using UV-Vis titration, circular dichroism and fluorescence spectroscopy. (AU)

Processo FAPESP: 22/14041-0 - Planejamento e investigação do potencial antitumoral de complexos metálicos contra células metastáticas e/ou quimiorresistentes
Beneficiário:Adelino Vieira de Godoy Netto
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 17/15850-0 - Difração de raios X como ferramenta no desenvolvimento de potenciais fármacos
Beneficiário:Eduardo Ernesto Castellano
Modalidade de apoio: Auxílio à Pesquisa - Temático